EXACT Sciences Corporation (EXAS) Names Michael S. Wygza To Its Board Of Directors

Exact Sciences Corp. (NASDAQ: EXAS) today announced the appointment of Michael S. Wygza to its board of directors. Wygza most recently served as President, Chief Executive Officer and a member of the board of directors of Radius Health, Inc.

Suggested Articles

EQRx is adding a pair of PD-1/PD-L1 meds to its pipeline through a deal with CStone worth $150 million upfront but could net the latter $1.15 billion.

All eyes are on Pfizer’s COVID-19 vaccine work, but the Big Pharma has today quietly culled two midstage trials and one phase 1 test.

All subjects had lower extremity weakness after receiving antisense oligonucleotide GTX-102, leading Ultragenyx to pause the study.